‘The undruggable became druggable’: a gamechanging treatment for the world’s deadliest cancer – podcast

**TL;DR:** ‘The undruggable became druggable’: a gamechanging treatment for the world’s deadliest cancer – podcast

---

A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a gamechanger and one of the biggest breakthroughs in decades. To find out more about how daraxonrasib works and how life-changing it could be for patients, Madeleine Finlay speaks to Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital Support the Guardian: theguardian.com/sciencepod Continue reading...

Source: Guardian Science

Tech news is rarely just a gadget headline. We frame what changed, who benefits, and what to watch next as details firm up.

Readers should treat early numbers and unnamed claims cautiously. The durable story is usually confirmed in docs, filings, or follow-up reporting.

Track whether the story affects total cost of ownership: subscriptions, compatibility, downtime risk, or support burden.

1) Separate the announcement from the shipping date. 2) Compare alternatives if pricing or terms shift. 3) Revisit the story when independent verification lands.

**Q: Is everything in this article confirmed?** A: The summary reflects publicly reported information at publication time. Analysis sections are clearly framed as context, not new reporting.

**Q: Will iByte update this page?** A: Yes. As primary sources publish more detail, this article can be refreshed without changing the URL.

Last updated: June 16, 2026.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.